4,4-Dimethyl-2,3-dihydropyrrol-5-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 亚胺内酰胺
• 英文名称: 4,4-Dimethyl-2,3-dihydropyrrol-5-amine
• 化学式: C₆H₁₂N₂
• 分子量: 112.17
• InChiKey: TZNJDGSLAAZRQS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  38.4
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• HIV integrase inhibitors
  申请人：Naidu Narasimhulu B.

  公开号：US20070111985A1

  公开（公告）日：2007-05-17

  The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

  这项发明涵盖了一系列公式I的双环嘧啶酮化合物，这些化合物抑制HIV整合酶并防止病毒整合到人类DNA中。这种作用使得这些化合物对治疗HIV感染和艾滋病有用。该发明还涵盖了用于治疗HIV感染者的药物组合物和方法。
• [EN] ANTI-PARASITIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ANTIPARASITAIRES ET LEURS UTILISATIONS
  申请人：MEMORIAL SLOAN KETTERING CANCER CENTER

  公开号：WO2017124087A1

  公开（公告）日：2017-07-20

  The present disclosure provides compounds of Formula (I'), Formula (II), and Formula (III). The compounds described herein may useful in treating and/or preventing protozoan infections in a subject in need thereof, treating and/or preventing trypanosomal infections (e.g., Trypanosoma cruzi (T. cruzi) or Trypanosoma brucei infections) and/or plasmodial infections in a subject in need thereof, treating and/or preventing diseases in a subject in need thereof (e.g., Chagas disease, malaria, and/or sleeping sickness), and may be useful in treating and/or preventing infectious diseases in a subject in need thereof. Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including a compound described herein.

  本公开提供了式(I')、式(II)和式(III)的化合物。本文描述的化合物可能有助于治疗和/或预防需要治疗的宿主中的原虫感染，治疗和/或预防锥虫感染（例如克氏锥虫（T. cruzi）或布鲁氏锥虫感染）和/或需要治疗的宿主中的疟原虫感染，治疗和/或预防需要治疗的宿主中的疾病（例如恙虫病、疟疾和/或睡眠病），并且可能有助于治疗和/或预防需要治疗的宿主中的传染病。本公开还提供了包括本文描述的化合物的药物组合物、试剂盒、方法和用途。
• Bicyclic heterocycles as HIV integrase inhibitors
  申请人：Naidu Narasimhulu B.

  公开号：US20050267131A1

  公开（公告）日：2005-12-01

  The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

  该发明涵盖了一系列公式I的环状双环杂环化合物，它们是HIV整合酶的抑制剂，可以防止病毒整合到人类DNA中。这种作用使这些化合物对治疗HIV感染和艾滋病有用。该发明还涵盖了治疗HIV感染者的药物组合物和方法。
• PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS
  申请人：Relay Therapeutics, Inc.

  公开号：US20200172546A1

  公开（公告）日：2020-06-04

  The present disclosure relates to compounds of formula (I) and pharmaceutical compositions thereof, and methods for inhibiting the activity of SHP2 phosphatase with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with SHP2 deregulation with the compounds and compositions of the disclosure
• PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
  申请人：Relay Therapeutics, Inc.

  公开号：US20210069188A1

  公开（公告）日：2021-03-11

  The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of SHP2 phosphatase with the compounds and compositions of the disclosure. The present disclosure further relates to methods for treating disorders associated with SHP2 deregulation with the compounds and compositions of the disclosure.